elranatamab will improve the degree or result of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Elranatamab causes cytokine release syndrome (CRS) which will suppress activity of CYP enzymes, causing increased exposure of CYP substrates.Pediatric Ideal experiments executed thus far haven't demons